Your browser doesn't support javascript.
loading
Is completion axillary lymph node dissection necessary in patients who are underrepresented in the ACOSOG Z0011 trial?
Gebhardt, Brian J; Thomas, Joel; Horne, Zachary D; Champ, Colin E; Farrugia, Daniel J; Diego, Emilia; Ahrendt, Gretchen M; Beriwal, Sushil.
Afiliação
  • Gebhardt BJ; Department of Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.
  • Thomas J; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Horne ZD; Department of Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.
  • Champ CE; Department of Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.
  • Farrugia DJ; Department of Surgical Oncology, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.
  • Diego E; Department of Surgical Oncology, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.
  • Ahrendt GM; Department of Surgical Oncology, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.
  • Beriwal S; Department of Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.
Adv Radiat Oncol ; 3(3): 258-264, 2018.
Article em En | MEDLINE | ID: mdl-30197938

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article